Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Juan José Ortiz-Zamudio"'
Autor:
Juan Eduardo Reséndiz-Galván, Nadia Hernández-Villa, Lourdes Cecilia Correa-González, Juan José Ortiz-Zamudio, Silvia Romano-Moreno, Miriam Nayeli Morales-Barragán, Susanna Edith Medellín-Garibay, Rosa del Carmen Milán-Segovia, Karla Paulina Valero-Rivera
Publikováno v:
Cancer Chemotherapy and Pharmacology. 85:21-31
To develop and validate a population pharmacokinetic model of Methotrexate (MTX) in Mexican children with acute lymphoblastic leukemia (ALL) for the design of personalized dosage regimens based on the anthropometric and physiological characteristics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54dcaaf2214f4ea4621b219dc0748166
https://doi.org/10.1007/s00280-019-03977-1
https://doi.org/10.1007/s00280-019-03977-1
Autor:
Rocío Gómez, Ildemar Alvarado-Morales, Diana P. Portales-Pérez, Cristian Jazmín Rodríguez-Pinal, Juan José Ortiz-Zamudio, Raúl A. Salazar-González, Rosa del Carmen Milán-Segovia, Verónica del Carmen Martínez-Jiménez, Lourdes Cecilia Correa-González, Oswaldo Hernández-González
Publikováno v:
Leukemia & Lymphoma. 59:1968-1975
Acute lymphoblastic leukemia (ALL) is one of the main causes of death in children and is associated with both genetic susceptibility and environmental factors. Genes encoding the arylamine N-acetyltransferases 1 and 2 (NAT1 and NAT2) isoenzymes are h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc6700be648b53a2613aeed71d4961cf
https://doi.org/10.1080/10428194.2017.1406090
https://doi.org/10.1080/10428194.2017.1406090